Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. 29 November 2019. Steve Dyson.

Executive Summary

The health-care sector remains ripe for investments, according to an expert panel of private equity investors. See what Steve Dyson, partner at UK private equity firm Apax Partners, said about it during a panel discussion at the recent Jefferies Healthcare Conference in London.

“"If you take medtech, some of the large medtech stocks are driving some of the strongest, high single digits, growth rates. That hasn't been the case for many years (2010 to 2015). What was 2-3% growth is now becoming a sustainable 5-6% growth." – Steve Dyson, partner, Apax Partners

Click here for a free trial of Medtech Insight

Related Content

Topics

UsernamePublicRestriction

Register

MT125955

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel